Global Oseltamivir Phosphate Antiviral Drug Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Oseltamivir Phosphate Antiviral Drug market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Tamiflu (oseltamivir phosphate) is an oral anti-viral drug approved for the treatment of acute, uncomplicated influenza in patients 2 weeks of age and older whose flu symptoms have not lasted more than two days
This report is a detailed and comprehensive analysis for global Oseltamivir Phosphate Antiviral Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oseltamivir Phosphate Antiviral Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oseltamivir Phosphate Antiviral Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oseltamivir Phosphate Antiviral Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oseltamivir Phosphate Antiviral Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oseltamivir Phosphate Antiviral Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oseltamivir Phosphate Antiviral Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Group, Alvogen, Teva Pharmaceuticals, Camber Pharmaceuticals and LUPINE Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Oseltamivir Phosphate Antiviral Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Oseltamivir Phosphate Antiviral Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oseltamivir Phosphate Antiviral Drug, with price, sales, revenue and global market share of Oseltamivir Phosphate Antiviral Drug from 2018 to 2023.
Chapter 3, the Oseltamivir Phosphate Antiviral Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oseltamivir Phosphate Antiviral Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oseltamivir Phosphate Antiviral Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oseltamivir Phosphate Antiviral Drug.
Chapter 14 and 15, to describe Oseltamivir Phosphate Antiviral Drug sales channel, distributors, customers, research findings and conclusion.
Tamiflu (oseltamivir phosphate) is an oral anti-viral drug approved for the treatment of acute, uncomplicated influenza in patients 2 weeks of age and older whose flu symptoms have not lasted more than two days
This report is a detailed and comprehensive analysis for global Oseltamivir Phosphate Antiviral Drug market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Oseltamivir Phosphate Antiviral Drug market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oseltamivir Phosphate Antiviral Drug market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oseltamivir Phosphate Antiviral Drug market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Oseltamivir Phosphate Antiviral Drug market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Oseltamivir Phosphate Antiviral Drug
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Oseltamivir Phosphate Antiviral Drug market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Roche Group, Alvogen, Teva Pharmaceuticals, Camber Pharmaceuticals and LUPINE Limited, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Oseltamivir Phosphate Antiviral Drug market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Capsule
- Suspension
- Child
- Aldult
- Roche Group
- Alvogen
- Teva Pharmaceuticals
- Camber Pharmaceuticals
- LUPINE Limited
- Amneal Pharmaceuticals
- Novadoz
- Natco Pharma
- Strides Pharma Inc.
- Zydus Cadila
- Alembic Pharmaceuticals
- Hetero Group
- Macleods Pharmaceuticals
- Ajanta Pharma
- HEC ChangJiang Pharmaceutical
- SL Pharmaceutica
- BrightGene Bio-Medical Technology
- Kelun Pharmaceutical
- Cspc Holdings
- North America (United States, Canada and Mexico)
- Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
- South America (Brazil, Argentina, Colombia, and Rest of South America)
- Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Chapter 1, to describe Oseltamivir Phosphate Antiviral Drug product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Oseltamivir Phosphate Antiviral Drug, with price, sales, revenue and global market share of Oseltamivir Phosphate Antiviral Drug from 2018 to 2023.
Chapter 3, the Oseltamivir Phosphate Antiviral Drug competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Oseltamivir Phosphate Antiviral Drug breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Oseltamivir Phosphate Antiviral Drug market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Oseltamivir Phosphate Antiviral Drug.
Chapter 14 and 15, to describe Oseltamivir Phosphate Antiviral Drug sales channel, distributors, customers, research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Oseltamivir Phosphate Antiviral Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Capsule
1.3.3 Suspension
1.4 Market Analysis by Application
1.4.1 Overview: Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Child
1.4.3 Aldult
1.5 Global Oseltamivir Phosphate Antiviral Drug Market Size & Forecast
1.5.1 Global Oseltamivir Phosphate Antiviral Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oseltamivir Phosphate Antiviral Drug Sales Quantity (2018-2029)
1.5.3 Global Oseltamivir Phosphate Antiviral Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche Group
2.1.1 Roche Group Details
2.1.2 Roche Group Major Business
2.1.3 Roche Group Oseltamivir Phosphate Antiviral Drug Product and Services
2.1.4 Roche Group Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Group Recent Developments/Updates
2.2 Alvogen
2.2.1 Alvogen Details
2.2.2 Alvogen Major Business
2.2.3 Alvogen Oseltamivir Phosphate Antiviral Drug Product and Services
2.2.4 Alvogen Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Alvogen Recent Developments/Updates
2.3 Teva Pharmaceuticals
2.3.1 Teva Pharmaceuticals Details
2.3.2 Teva Pharmaceuticals Major Business
2.3.3 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
2.3.4 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Pharmaceuticals Recent Developments/Updates
2.4 Camber Pharmaceuticals
2.4.1 Camber Pharmaceuticals Details
2.4.2 Camber Pharmaceuticals Major Business
2.4.3 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
2.4.4 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Camber Pharmaceuticals Recent Developments/Updates
2.5 LUPINE Limited
2.5.1 LUPINE Limited Details
2.5.2 LUPINE Limited Major Business
2.5.3 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product and Services
2.5.4 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 LUPINE Limited Recent Developments/Updates
2.6 Amneal Pharmaceuticals
2.6.1 Amneal Pharmaceuticals Details
2.6.2 Amneal Pharmaceuticals Major Business
2.6.3 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
2.6.4 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Amneal Pharmaceuticals Recent Developments/Updates
2.7 Novadoz
2.7.1 Novadoz Details
2.7.2 Novadoz Major Business
2.7.3 Novadoz Oseltamivir Phosphate Antiviral Drug Product and Services
2.7.4 Novadoz Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novadoz Recent Developments/Updates
2.8 Natco Pharma
2.8.1 Natco Pharma Details
2.8.2 Natco Pharma Major Business
2.8.3 Natco Pharma Oseltamivir Phosphate Antiviral Drug Product and Services
2.8.4 Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Natco Pharma Recent Developments/Updates
2.9 Strides Pharma Inc.
2.9.1 Strides Pharma Inc. Details
2.9.2 Strides Pharma Inc. Major Business
2.9.3 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product and Services
2.9.4 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Strides Pharma Inc. Recent Developments/Updates
2.10 Zydus Cadila
2.10.1 Zydus Cadila Details
2.10.2 Zydus Cadila Major Business
2.10.3 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product and Services
2.10.4 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Zydus Cadila Recent Developments/Updates
2.11 Alembic Pharmaceuticals
2.11.1 Alembic Pharmaceuticals Details
2.11.2 Alembic Pharmaceuticals Major Business
2.11.3 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
2.11.4 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Alembic Pharmaceuticals Recent Developments/Updates
2.12 Hetero Group
2.12.1 Hetero Group Details
2.12.2 Hetero Group Major Business
2.12.3 Hetero Group Oseltamivir Phosphate Antiviral Drug Product and Services
2.12.4 Hetero Group Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hetero Group Recent Developments/Updates
2.13 Macleods Pharmaceuticals
2.13.1 Macleods Pharmaceuticals Details
2.13.2 Macleods Pharmaceuticals Major Business
2.13.3 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
2.13.4 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Macleods Pharmaceuticals Recent Developments/Updates
2.14 Ajanta Pharma
2.14.1 Ajanta Pharma Details
2.14.2 Ajanta Pharma Major Business
2.14.3 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product and Services
2.14.4 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Ajanta Pharma Recent Developments/Updates
2.15 HEC ChangJiang Pharmaceutical
2.15.1 HEC ChangJiang Pharmaceutical Details
2.15.2 HEC ChangJiang Pharmaceutical Major Business
2.15.3 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product and Services
2.15.4 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 HEC ChangJiang Pharmaceutical Recent Developments/Updates
2.16 SL Pharmaceutica
2.16.1 SL Pharmaceutica Details
2.16.2 SL Pharmaceutica Major Business
2.16.3 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product and Services
2.16.4 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 SL Pharmaceutica Recent Developments/Updates
2.17 BrightGene Bio-Medical Technology
2.17.1 BrightGene Bio-Medical Technology Details
2.17.2 BrightGene Bio-Medical Technology Major Business
2.17.3 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product and Services
2.17.4 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 BrightGene Bio-Medical Technology Recent Developments/Updates
2.18 Kelun Pharmaceutical
2.18.1 Kelun Pharmaceutical Details
2.18.2 Kelun Pharmaceutical Major Business
2.18.3 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product and Services
2.18.4 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Kelun Pharmaceutical Recent Developments/Updates
2.19 Cspc Holdings
2.19.1 Cspc Holdings Details
2.19.2 Cspc Holdings Major Business
2.19.3 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product and Services
2.19.4 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Cspc Holdings Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OSELTAMIVIR PHOSPHATE ANTIVIRAL DRUG BY MANUFACTURER
3.1 Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Manufacturer (2018-2023)
3.3 Global Oseltamivir Phosphate Antiviral Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oseltamivir Phosphate Antiviral Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oseltamivir Phosphate Antiviral Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Oseltamivir Phosphate Antiviral Drug Manufacturer Market Share in 2022
3.5 Oseltamivir Phosphate Antiviral Drug Market: Overall Company Footprint Analysis
3.5.1 Oseltamivir Phosphate Antiviral Drug Market: Region Footprint
3.5.2 Oseltamivir Phosphate Antiviral Drug Market: Company Product Type Footprint
3.5.3 Oseltamivir Phosphate Antiviral Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Oseltamivir Phosphate Antiviral Drug Market Size by Region
4.1.1 Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2018-2029)
4.1.3 Global Oseltamivir Phosphate Antiviral Drug Average Price by Region (2018-2029)
4.2 North America Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029)
4.3 Europe Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029)
4.5 South America Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
5.2 Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type (2018-2029)
5.3 Global Oseltamivir Phosphate Antiviral Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
6.2 Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application (2018-2029)
6.3 Global Oseltamivir Phosphate Antiviral Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
7.2 North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
7.3 North America Oseltamivir Phosphate Antiviral Drug Market Size by Country
7.3.1 North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
8.2 Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
8.3 Europe Oseltamivir Phosphate Antiviral Drug Market Size by Country
8.3.1 Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Size by Region
9.3.1 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
10.2 South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
10.3 South America Oseltamivir Phosphate Antiviral Drug Market Size by Country
10.3.1 South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Market Size by Country
11.3.1 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Oseltamivir Phosphate Antiviral Drug Market Drivers
12.2 Oseltamivir Phosphate Antiviral Drug Market Restraints
12.3 Oseltamivir Phosphate Antiviral Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Oseltamivir Phosphate Antiviral Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oseltamivir Phosphate Antiviral Drug
13.3 Oseltamivir Phosphate Antiviral Drug Production Process
13.4 Oseltamivir Phosphate Antiviral Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oseltamivir Phosphate Antiviral Drug Typical Distributors
14.3 Oseltamivir Phosphate Antiviral Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
1.1 Product Overview and Scope of Oseltamivir Phosphate Antiviral Drug
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Capsule
1.3.3 Suspension
1.4 Market Analysis by Application
1.4.1 Overview: Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Child
1.4.3 Aldult
1.5 Global Oseltamivir Phosphate Antiviral Drug Market Size & Forecast
1.5.1 Global Oseltamivir Phosphate Antiviral Drug Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Oseltamivir Phosphate Antiviral Drug Sales Quantity (2018-2029)
1.5.3 Global Oseltamivir Phosphate Antiviral Drug Average Price (2018-2029)
2 MANUFACTURERS PROFILES
2.1 Roche Group
2.1.1 Roche Group Details
2.1.2 Roche Group Major Business
2.1.3 Roche Group Oseltamivir Phosphate Antiviral Drug Product and Services
2.1.4 Roche Group Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Roche Group Recent Developments/Updates
2.2 Alvogen
2.2.1 Alvogen Details
2.2.2 Alvogen Major Business
2.2.3 Alvogen Oseltamivir Phosphate Antiviral Drug Product and Services
2.2.4 Alvogen Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Alvogen Recent Developments/Updates
2.3 Teva Pharmaceuticals
2.3.1 Teva Pharmaceuticals Details
2.3.2 Teva Pharmaceuticals Major Business
2.3.3 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
2.3.4 Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Teva Pharmaceuticals Recent Developments/Updates
2.4 Camber Pharmaceuticals
2.4.1 Camber Pharmaceuticals Details
2.4.2 Camber Pharmaceuticals Major Business
2.4.3 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
2.4.4 Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Camber Pharmaceuticals Recent Developments/Updates
2.5 LUPINE Limited
2.5.1 LUPINE Limited Details
2.5.2 LUPINE Limited Major Business
2.5.3 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product and Services
2.5.4 LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 LUPINE Limited Recent Developments/Updates
2.6 Amneal Pharmaceuticals
2.6.1 Amneal Pharmaceuticals Details
2.6.2 Amneal Pharmaceuticals Major Business
2.6.3 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
2.6.4 Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Amneal Pharmaceuticals Recent Developments/Updates
2.7 Novadoz
2.7.1 Novadoz Details
2.7.2 Novadoz Major Business
2.7.3 Novadoz Oseltamivir Phosphate Antiviral Drug Product and Services
2.7.4 Novadoz Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Novadoz Recent Developments/Updates
2.8 Natco Pharma
2.8.1 Natco Pharma Details
2.8.2 Natco Pharma Major Business
2.8.3 Natco Pharma Oseltamivir Phosphate Antiviral Drug Product and Services
2.8.4 Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Natco Pharma Recent Developments/Updates
2.9 Strides Pharma Inc.
2.9.1 Strides Pharma Inc. Details
2.9.2 Strides Pharma Inc. Major Business
2.9.3 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product and Services
2.9.4 Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Strides Pharma Inc. Recent Developments/Updates
2.10 Zydus Cadila
2.10.1 Zydus Cadila Details
2.10.2 Zydus Cadila Major Business
2.10.3 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product and Services
2.10.4 Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 Zydus Cadila Recent Developments/Updates
2.11 Alembic Pharmaceuticals
2.11.1 Alembic Pharmaceuticals Details
2.11.2 Alembic Pharmaceuticals Major Business
2.11.3 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
2.11.4 Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Alembic Pharmaceuticals Recent Developments/Updates
2.12 Hetero Group
2.12.1 Hetero Group Details
2.12.2 Hetero Group Major Business
2.12.3 Hetero Group Oseltamivir Phosphate Antiviral Drug Product and Services
2.12.4 Hetero Group Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Hetero Group Recent Developments/Updates
2.13 Macleods Pharmaceuticals
2.13.1 Macleods Pharmaceuticals Details
2.13.2 Macleods Pharmaceuticals Major Business
2.13.3 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
2.13.4 Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Macleods Pharmaceuticals Recent Developments/Updates
2.14 Ajanta Pharma
2.14.1 Ajanta Pharma Details
2.14.2 Ajanta Pharma Major Business
2.14.3 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product and Services
2.14.4 Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 Ajanta Pharma Recent Developments/Updates
2.15 HEC ChangJiang Pharmaceutical
2.15.1 HEC ChangJiang Pharmaceutical Details
2.15.2 HEC ChangJiang Pharmaceutical Major Business
2.15.3 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product and Services
2.15.4 HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 HEC ChangJiang Pharmaceutical Recent Developments/Updates
2.16 SL Pharmaceutica
2.16.1 SL Pharmaceutica Details
2.16.2 SL Pharmaceutica Major Business
2.16.3 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product and Services
2.16.4 SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 SL Pharmaceutica Recent Developments/Updates
2.17 BrightGene Bio-Medical Technology
2.17.1 BrightGene Bio-Medical Technology Details
2.17.2 BrightGene Bio-Medical Technology Major Business
2.17.3 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product and Services
2.17.4 BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.17.5 BrightGene Bio-Medical Technology Recent Developments/Updates
2.18 Kelun Pharmaceutical
2.18.1 Kelun Pharmaceutical Details
2.18.2 Kelun Pharmaceutical Major Business
2.18.3 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product and Services
2.18.4 Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.18.5 Kelun Pharmaceutical Recent Developments/Updates
2.19 Cspc Holdings
2.19.1 Cspc Holdings Details
2.19.2 Cspc Holdings Major Business
2.19.3 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product and Services
2.19.4 Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.19.5 Cspc Holdings Recent Developments/Updates
3 COMPETITIVE ENVIRONMENT: OSELTAMIVIR PHOSPHATE ANTIVIRAL DRUG BY MANUFACTURER
3.1 Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Manufacturer (2018-2023)
3.2 Global Oseltamivir Phosphate Antiviral Drug Revenue by Manufacturer (2018-2023)
3.3 Global Oseltamivir Phosphate Antiviral Drug Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Oseltamivir Phosphate Antiviral Drug by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Oseltamivir Phosphate Antiviral Drug Manufacturer Market Share in 2022
3.4.2 Top 6 Oseltamivir Phosphate Antiviral Drug Manufacturer Market Share in 2022
3.5 Oseltamivir Phosphate Antiviral Drug Market: Overall Company Footprint Analysis
3.5.1 Oseltamivir Phosphate Antiviral Drug Market: Region Footprint
3.5.2 Oseltamivir Phosphate Antiviral Drug Market: Company Product Type Footprint
3.5.3 Oseltamivir Phosphate Antiviral Drug Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 CONSUMPTION ANALYSIS BY REGION
4.1 Global Oseltamivir Phosphate Antiviral Drug Market Size by Region
4.1.1 Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2018-2029)
4.1.2 Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2018-2029)
4.1.3 Global Oseltamivir Phosphate Antiviral Drug Average Price by Region (2018-2029)
4.2 North America Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029)
4.3 Europe Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029)
4.4 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029)
4.5 South America Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029)
4.6 Middle East and Africa Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029)
5 MARKET SEGMENT BY TYPE
5.1 Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
5.2 Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type (2018-2029)
5.3 Global Oseltamivir Phosphate Antiviral Drug Average Price by Type (2018-2029)
6 MARKET SEGMENT BY APPLICATION
6.1 Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
6.2 Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application (2018-2029)
6.3 Global Oseltamivir Phosphate Antiviral Drug Average Price by Application (2018-2029)
7 NORTH AMERICA
7.1 North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
7.2 North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
7.3 North America Oseltamivir Phosphate Antiviral Drug Market Size by Country
7.3.1 North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2029)
7.3.2 North America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 EUROPE
8.1 Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
8.2 Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
8.3 Europe Oseltamivir Phosphate Antiviral Drug Market Size by Country
8.3.1 Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2029)
8.3.2 Europe Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 ASIA-PACIFIC
9.1 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Market Size by Region
9.3.1 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 SOUTH AMERICA
10.1 South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
10.2 South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
10.3 South America Oseltamivir Phosphate Antiviral Drug Market Size by Country
10.3.1 South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2029)
10.3.2 South America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 MIDDLE EAST & AFRICA
11.1 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Market Size by Country
11.3.1 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 MARKET DYNAMICS
12.1 Oseltamivir Phosphate Antiviral Drug Market Drivers
12.2 Oseltamivir Phosphate Antiviral Drug Market Restraints
12.3 Oseltamivir Phosphate Antiviral Drug Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 RAW MATERIAL AND INDUSTRY CHAIN
13.1 Raw Material of Oseltamivir Phosphate Antiviral Drug and Key Manufacturers
13.2 Manufacturing Costs Percentage of Oseltamivir Phosphate Antiviral Drug
13.3 Oseltamivir Phosphate Antiviral Drug Production Process
13.4 Oseltamivir Phosphate Antiviral Drug Industrial Chain
14 SHIPMENTS BY DISTRIBUTION CHANNEL
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Oseltamivir Phosphate Antiviral Drug Typical Distributors
14.3 Oseltamivir Phosphate Antiviral Drug Typical Customers
15 RESEARCH FINDINGS AND CONCLUSION
16 APPENDIX
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
LIST OF TABLES
Table 1. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Group Basic Information, Manufacturing Base and Competitors
Table 4. Roche Group Major Business
Table 5. Roche Group Oseltamivir Phosphate Antiviral Drug Product and Services
Table 6. Roche Group Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Group Recent Developments/Updates
Table 8. Alvogen Basic Information, Manufacturing Base and Competitors
Table 9. Alvogen Major Business
Table 10. Alvogen Oseltamivir Phosphate Antiviral Drug Product and Services
Table 11. Alvogen Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Alvogen Recent Developments/Updates
Table 13. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceuticals Major Business
Table 15. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
Table 16. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teva Pharmaceuticals Recent Developments/Updates
Table 18. Camber Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Camber Pharmaceuticals Major Business
Table 20. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
Table 21. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Camber Pharmaceuticals Recent Developments/Updates
Table 23. LUPINE Limited Basic Information, Manufacturing Base and Competitors
Table 24. LUPINE Limited Major Business
Table 25. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product and Services
Table 26. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. LUPINE Limited Recent Developments/Updates
Table 28. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Amneal Pharmaceuticals Major Business
Table 30. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
Table 31. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Amneal Pharmaceuticals Recent Developments/Updates
Table 33. Novadoz Basic Information, Manufacturing Base and Competitors
Table 34. Novadoz Major Business
Table 35. Novadoz Oseltamivir Phosphate Antiviral Drug Product and Services
Table 36. Novadoz Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novadoz Recent Developments/Updates
Table 38. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Natco Pharma Major Business
Table 40. Natco Pharma Oseltamivir Phosphate Antiviral Drug Product and Services
Table 41. Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Natco Pharma Recent Developments/Updates
Table 43. Strides Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Strides Pharma Inc. Major Business
Table 45. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product and Services
Table 46. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Strides Pharma Inc. Recent Developments/Updates
Table 48. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 49. Zydus Cadila Major Business
Table 50. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product and Services
Table 51. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Zydus Cadila Recent Developments/Updates
Table 53. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Alembic Pharmaceuticals Major Business
Table 55. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
Table 56. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Alembic Pharmaceuticals Recent Developments/Updates
Table 58. Hetero Group Basic Information, Manufacturing Base and Competitors
Table 59. Hetero Group Major Business
Table 60. Hetero Group Oseltamivir Phosphate Antiviral Drug Product and Services
Table 61. Hetero Group Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Hetero Group Recent Developments/Updates
Table 63. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Macleods Pharmaceuticals Major Business
Table 65. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
Table 66. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Macleods Pharmaceuticals Recent Developments/Updates
Table 68. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Ajanta Pharma Major Business
Table 70. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product and Services
Table 71. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Ajanta Pharma Recent Developments/Updates
Table 73. HEC ChangJiang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. HEC ChangJiang Pharmaceutical Major Business
Table 75. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product and Services
Table 76. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. HEC ChangJiang Pharmaceutical Recent Developments/Updates
Table 78. SL Pharmaceutica Basic Information, Manufacturing Base and Competitors
Table 79. SL Pharmaceutica Major Business
Table 80. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product and Services
Table 81. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. SL Pharmaceutica Recent Developments/Updates
Table 83. BrightGene Bio-Medical Technology Basic Information, Manufacturing Base and Competitors
Table 84. BrightGene Bio-Medical Technology Major Business
Table 85. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product and Services
Table 86. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. BrightGene Bio-Medical Technology Recent Developments/Updates
Table 88. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Kelun Pharmaceutical Major Business
Table 90. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product and Services
Table 91. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Kelun Pharmaceutical Recent Developments/Updates
Table 93. Cspc Holdings Basic Information, Manufacturing Base and Competitors
Table 94. Cspc Holdings Major Business
Table 95. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product and Services
Table 96. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Cspc Holdings Recent Developments/Updates
Table 98. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global Oseltamivir Phosphate Antiviral Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Oseltamivir Phosphate Antiviral Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 101. Market Position of Manufacturers in Oseltamivir Phosphate Antiviral Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Oseltamivir Phosphate Antiviral Drug Production Site of Key Manufacturer
Table 103. Oseltamivir Phosphate Antiviral Drug Market: Company Product Type Footprint
Table 104. Oseltamivir Phosphate Antiviral Drug Market: Company Product Application Footprint
Table 105. Oseltamivir Phosphate Antiviral Drug New Market Entrants and Barriers to Market Entry
Table 106. Oseltamivir Phosphate Antiviral Drug Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Oseltamivir Phosphate Antiviral Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 112. Global Oseltamivir Phosphate Antiviral Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 113. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Oseltamivir Phosphate Antiviral Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 118. Global Oseltamivir Phosphate Antiviral Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 119. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Oseltamivir Phosphate Antiviral Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 124. Global Oseltamivir Phosphate Antiviral Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 125. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Oseltamivir Phosphate Antiviral Drug Raw Material
Table 166. Key Manufacturers of Oseltamivir Phosphate Antiviral Drug Raw Materials
Table 167. Oseltamivir Phosphate Antiviral Drug Typical Distributors
Table 168. Oseltamivir Phosphate Antiviral Drug Typical Customers
Table 1. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Roche Group Basic Information, Manufacturing Base and Competitors
Table 4. Roche Group Major Business
Table 5. Roche Group Oseltamivir Phosphate Antiviral Drug Product and Services
Table 6. Roche Group Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Roche Group Recent Developments/Updates
Table 8. Alvogen Basic Information, Manufacturing Base and Competitors
Table 9. Alvogen Major Business
Table 10. Alvogen Oseltamivir Phosphate Antiviral Drug Product and Services
Table 11. Alvogen Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Alvogen Recent Developments/Updates
Table 13. Teva Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 14. Teva Pharmaceuticals Major Business
Table 15. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
Table 16. Teva Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Teva Pharmaceuticals Recent Developments/Updates
Table 18. Camber Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 19. Camber Pharmaceuticals Major Business
Table 20. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
Table 21. Camber Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Camber Pharmaceuticals Recent Developments/Updates
Table 23. LUPINE Limited Basic Information, Manufacturing Base and Competitors
Table 24. LUPINE Limited Major Business
Table 25. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Product and Services
Table 26. LUPINE Limited Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. LUPINE Limited Recent Developments/Updates
Table 28. Amneal Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 29. Amneal Pharmaceuticals Major Business
Table 30. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
Table 31. Amneal Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. Amneal Pharmaceuticals Recent Developments/Updates
Table 33. Novadoz Basic Information, Manufacturing Base and Competitors
Table 34. Novadoz Major Business
Table 35. Novadoz Oseltamivir Phosphate Antiviral Drug Product and Services
Table 36. Novadoz Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Novadoz Recent Developments/Updates
Table 38. Natco Pharma Basic Information, Manufacturing Base and Competitors
Table 39. Natco Pharma Major Business
Table 40. Natco Pharma Oseltamivir Phosphate Antiviral Drug Product and Services
Table 41. Natco Pharma Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Natco Pharma Recent Developments/Updates
Table 43. Strides Pharma Inc. Basic Information, Manufacturing Base and Competitors
Table 44. Strides Pharma Inc. Major Business
Table 45. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Product and Services
Table 46. Strides Pharma Inc. Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. Strides Pharma Inc. Recent Developments/Updates
Table 48. Zydus Cadila Basic Information, Manufacturing Base and Competitors
Table 49. Zydus Cadila Major Business
Table 50. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Product and Services
Table 51. Zydus Cadila Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. Zydus Cadila Recent Developments/Updates
Table 53. Alembic Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 54. Alembic Pharmaceuticals Major Business
Table 55. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
Table 56. Alembic Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Alembic Pharmaceuticals Recent Developments/Updates
Table 58. Hetero Group Basic Information, Manufacturing Base and Competitors
Table 59. Hetero Group Major Business
Table 60. Hetero Group Oseltamivir Phosphate Antiviral Drug Product and Services
Table 61. Hetero Group Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Hetero Group Recent Developments/Updates
Table 63. Macleods Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 64. Macleods Pharmaceuticals Major Business
Table 65. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Product and Services
Table 66. Macleods Pharmaceuticals Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Macleods Pharmaceuticals Recent Developments/Updates
Table 68. Ajanta Pharma Basic Information, Manufacturing Base and Competitors
Table 69. Ajanta Pharma Major Business
Table 70. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Product and Services
Table 71. Ajanta Pharma Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. Ajanta Pharma Recent Developments/Updates
Table 73. HEC ChangJiang Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. HEC ChangJiang Pharmaceutical Major Business
Table 75. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product and Services
Table 76. HEC ChangJiang Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. HEC ChangJiang Pharmaceutical Recent Developments/Updates
Table 78. SL Pharmaceutica Basic Information, Manufacturing Base and Competitors
Table 79. SL Pharmaceutica Major Business
Table 80. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Product and Services
Table 81. SL Pharmaceutica Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. SL Pharmaceutica Recent Developments/Updates
Table 83. BrightGene Bio-Medical Technology Basic Information, Manufacturing Base and Competitors
Table 84. BrightGene Bio-Medical Technology Major Business
Table 85. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Product and Services
Table 86. BrightGene Bio-Medical Technology Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 87. BrightGene Bio-Medical Technology Recent Developments/Updates
Table 88. Kelun Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 89. Kelun Pharmaceutical Major Business
Table 90. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Product and Services
Table 91. Kelun Pharmaceutical Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 92. Kelun Pharmaceutical Recent Developments/Updates
Table 93. Cspc Holdings Basic Information, Manufacturing Base and Competitors
Table 94. Cspc Holdings Major Business
Table 95. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Product and Services
Table 96. Cspc Holdings Oseltamivir Phosphate Antiviral Drug Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 97. Cspc Holdings Recent Developments/Updates
Table 98. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 99. Global Oseltamivir Phosphate Antiviral Drug Revenue by Manufacturer (2018-2023) & (USD Million)
Table 100. Global Oseltamivir Phosphate Antiviral Drug Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 101. Market Position of Manufacturers in Oseltamivir Phosphate Antiviral Drug, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 102. Head Office and Oseltamivir Phosphate Antiviral Drug Production Site of Key Manufacturer
Table 103. Oseltamivir Phosphate Antiviral Drug Market: Company Product Type Footprint
Table 104. Oseltamivir Phosphate Antiviral Drug Market: Company Product Application Footprint
Table 105. Oseltamivir Phosphate Antiviral Drug New Market Entrants and Barriers to Market Entry
Table 106. Oseltamivir Phosphate Antiviral Drug Mergers, Acquisition, Agreements, and Collaborations
Table 107. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 108. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 109. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 110. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 111. Global Oseltamivir Phosphate Antiviral Drug Average Price by Region (2018-2023) & (US$/Unit)
Table 112. Global Oseltamivir Phosphate Antiviral Drug Average Price by Region (2024-2029) & (US$/Unit)
Table 113. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 114. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 115. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type (2018-2023) & (USD Million)
Table 116. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type (2024-2029) & (USD Million)
Table 117. Global Oseltamivir Phosphate Antiviral Drug Average Price by Type (2018-2023) & (US$/Unit)
Table 118. Global Oseltamivir Phosphate Antiviral Drug Average Price by Type (2024-2029) & (US$/Unit)
Table 119. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 120. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 121. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application (2018-2023) & (USD Million)
Table 122. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application (2024-2029) & (USD Million)
Table 123. Global Oseltamivir Phosphate Antiviral Drug Average Price by Application (2018-2023) & (US$/Unit)
Table 124. Global Oseltamivir Phosphate Antiviral Drug Average Price by Application (2024-2029) & (US$/Unit)
Table 125. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 126. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 127. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 128. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 129. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 130. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 131. North America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 132. North America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 133. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 134. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 135. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 136. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 137. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 138. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 139. Europe Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 140. Europe Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 141. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 142. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 143. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 144. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 145. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 146. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 147. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 148. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 149. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 150. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 151. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 152. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 153. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2018-2023) & (K Units)
Table 154. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity by Country (2024-2029) & (K Units)
Table 155. South America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2018-2023) & (USD Million)
Table 156. South America Oseltamivir Phosphate Antiviral Drug Consumption Value by Country (2024-2029) & (USD Million)
Table 157. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2018-2023) & (K Units)
Table 158. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Type (2024-2029) & (K Units)
Table 159. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2018-2023) & (K Units)
Table 160. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Application (2024-2029) & (K Units)
Table 161. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2018-2023) & (K Units)
Table 162. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity by Region (2024-2029) & (K Units)
Table 163. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2018-2023) & (USD Million)
Table 164. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Consumption Value by Region (2024-2029) & (USD Million)
Table 165. Oseltamivir Phosphate Antiviral Drug Raw Material
Table 166. Key Manufacturers of Oseltamivir Phosphate Antiviral Drug Raw Materials
Table 167. Oseltamivir Phosphate Antiviral Drug Typical Distributors
Table 168. Oseltamivir Phosphate Antiviral Drug Typical Customers
LIST OF FIGURES
Figure 1. Oseltamivir Phosphate Antiviral Drug Picture
Figure 2. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Type in 2022
Figure 4. Capsule Examples
Figure 5. Suspension Examples
Figure 6. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Application in 2022
Figure 8. Child Examples
Figure 9. Aldult Examples
Figure 10. Global Oseltamivir Phosphate Antiviral Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Oseltamivir Phosphate Antiviral Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Oseltamivir Phosphate Antiviral Drug Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Oseltamivir Phosphate Antiviral Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Oseltamivir Phosphate Antiviral Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Oseltamivir Phosphate Antiviral Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Oseltamivir Phosphate Antiviral Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Oseltamivir Phosphate Antiviral Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Region (2018-2029)
Figure 52. China Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Oseltamivir Phosphate Antiviral Drug Market Drivers
Figure 73. Oseltamivir Phosphate Antiviral Drug Market Restraints
Figure 74. Oseltamivir Phosphate Antiviral Drug Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Oseltamivir Phosphate Antiviral Drug in 2022
Figure 77. Manufacturing Process Analysis of Oseltamivir Phosphate Antiviral Drug
Figure 78. Oseltamivir Phosphate Antiviral Drug Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Oseltamivir Phosphate Antiviral Drug Picture
Figure 2. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Type in 2022
Figure 4. Capsule Examples
Figure 5. Suspension Examples
Figure 6. Global Oseltamivir Phosphate Antiviral Drug Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 7. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Application in 2022
Figure 8. Child Examples
Figure 9. Aldult Examples
Figure 10. Global Oseltamivir Phosphate Antiviral Drug Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 11. Global Oseltamivir Phosphate Antiviral Drug Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 12. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity (2018-2029) & (K Units)
Figure 13. Global Oseltamivir Phosphate Antiviral Drug Average Price (2018-2029) & (US$/Unit)
Figure 14. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Manufacturer in 2022
Figure 15. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Manufacturer in 2022
Figure 16. Producer Shipments of Oseltamivir Phosphate Antiviral Drug by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 17. Top 3 Oseltamivir Phosphate Antiviral Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 18. Top 6 Oseltamivir Phosphate Antiviral Drug Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Region (2018-2029)
Figure 20. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Region (2018-2029)
Figure 21. North America Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 22. Europe Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 23. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 24. South America Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 25. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Consumption Value (2018-2029) & (USD Million)
Figure 26. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 27. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Type (2018-2029)
Figure 28. Global Oseltamivir Phosphate Antiviral Drug Average Price by Type (2018-2029) & (US$/Unit)
Figure 29. Global Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 30. Global Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Application (2018-2029)
Figure 31. Global Oseltamivir Phosphate Antiviral Drug Average Price by Application (2018-2029) & (US$/Unit)
Figure 32. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 33. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 34. North America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Country (2018-2029)
Figure 35. North America Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Country (2018-2029)
Figure 36. United States Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 37. Canada Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Mexico Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 40. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 41. Europe Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Country (2018-2029)
Figure 42. Europe Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Country (2018-2029)
Figure 43. Germany Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 44. France Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. United Kingdom Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. Russia Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Italy Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 49. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 50. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Region (2018-2029)
Figure 51. Asia-Pacific Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Region (2018-2029)
Figure 52. China Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 53. Japan Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Korea Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. India Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. Southeast Asia Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Australia Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 59. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 60. South America Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Country (2018-2029)
Figure 61. South America Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Country (2018-2029)
Figure 62. Brazil Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 63. Argentina Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Type (2018-2029)
Figure 65. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Application (2018-2029)
Figure 66. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Sales Quantity Market Share by Region (2018-2029)
Figure 67. Middle East & Africa Oseltamivir Phosphate Antiviral Drug Consumption Value Market Share by Region (2018-2029)
Figure 68. Turkey Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 69. Egypt Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Saudi Arabia Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. South Africa Oseltamivir Phosphate Antiviral Drug Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. Oseltamivir Phosphate Antiviral Drug Market Drivers
Figure 73. Oseltamivir Phosphate Antiviral Drug Market Restraints
Figure 74. Oseltamivir Phosphate Antiviral Drug Market Trends
Figure 75. Porters Five Forces Analysis
Figure 76. Manufacturing Cost Structure Analysis of Oseltamivir Phosphate Antiviral Drug in 2022
Figure 77. Manufacturing Process Analysis of Oseltamivir Phosphate Antiviral Drug
Figure 78. Oseltamivir Phosphate Antiviral Drug Industrial Chain
Figure 79. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 80. Direct Channel Pros & Cons
Figure 81. Indirect Channel Pros & Cons
Figure 82. Methodology
Figure 83. Research Process and Data Source
